Christopher M. Starr, PhD

Christopher M. Starr, PhD

Chair of the BoardatMonopar Therapeutics· In proxies 2023–2025

Christopher M. Starr, PhD sits on 2 public boards.

Experience

  1. Monopar TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +555%
  2. Glycomine Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Thiogenesis Therapeutics Corp.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?